MedWatch

Danish notified body expected approved in 2023

More than a year will pass before Denmark will once again have a notified body for the approval of medtech products. Industry association Medicoindustrien warns of a ”huge capacity crisis,” which will only grow – particularly affecting one part of the industry.

German Tüv Süd continues to be the only applicant to become a notified body in Denmark

BRUSSELS – Although the medtech industry warns of a greater ”capacity crisis,” the sector shouldn’t be expecting to have products approved locally in Denmark for sale in the EU any time soon.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs